Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06274944 · ClinicalTrials.gov registry record
Nasogastric/Orogastric Tube Placement Confirmation in Neonates Utilizing Self-contained pH Device, a Feasibility Study
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 12
- Enrollment target
NCT06274944: Completed study, sponsored by University of Minnesota.
NCT06274944 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06274944 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
This study is looking at using a self-contained pH device that will assist in confirming placement of a nasogastric or orogastric tube placed in the stomach of hospitalized infants.
Primary Outcome
Comparing the accuracy of the novel NG/OG tube placement device pH reading to the standard pH testing method.
Interventions
- DEVICE nasogastric tube placement pH confirmation device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2024-02-12 |
| Est. Completion | 2025-01-21 |
What the finished NCT06274944 record still lists
NCT06274944 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which nasogastric tube placement pH confirmation device is the first listed.
NCT06274944 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06274944 about?
NCT06274944 is a clinical study titled "Nasogastric/Orogastric Tube Placement Confirmation in Neonates Utilizing Self-contained pH Device, a Feasibility Study". This study is looking at using a self-contained pH device that will assist in confirming placement of a nasogastric or orogastric tube placed in the stomach of hospitalized infants.
What is the current status of trial NCT06274944?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2024-02-12. Estimated completion is 2025-01-21.
What interventions are being tested in trial NCT06274944?
The interventions under investigation include: nasogastric tube placement pH confirmation device (DEVICE).
Who is sponsoring clinical trial NCT06274944?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI